Your browser doesn't support javascript.
loading
Sonographic features of lymphoma of the major salivary glands diagnosed with ultrasound-guided core needle biopsy in Sjögren's syndrome.
Lorenzon, Michele; Tulipano Di Franco, Francesco; Zabotti, Alen; Pegolo, Enrico; Giovannini, Ivan; Manfrè, Valeria; Mansutti, Elisa; De Vita, Salvatore; Zuiani, Chiara; Girometti, Rossano.
Afiliação
  • Lorenzon M; Institute of Radiology, Department of Medicine, University of Udine, Italy. michele.lorenzon@gmail.com.
  • Tulipano Di Franco F; Institute of Radiology, Department of Medicine, University of Udine, Italy.
  • Zabotti A; Clinic of Rheumatology, Department of Medicine, University of Udine, Italy.
  • Pegolo E; Institute of Pathology, Department of Experimental and Clinical Medical Sciences, University of Udine, Italy.
  • Giovannini I; Clinic of Rheumatology, Department of Medicine, University of Udine, Italy.
  • Manfrè V; Clinic of Rheumatology, Department of Medicine, University of Udine, Italy.
  • Mansutti E; Department of General Medicine, Hospital of Latisana, ASUFC, Udine, Italy.
  • De Vita S; Clinic of Rheumatology, Department of Medicine, University of Udine, Italy.
  • Zuiani C; Institute of Radiology, Department of Medicine, University of Udine, Italy.
  • Girometti R; Institute of Radiology, Department of Medicine, University of Udine, Italy.
Clin Exp Rheumatol ; 39 Suppl 133(6): 175-183, 2021.
Article em En | MEDLINE | ID: mdl-34665707
ABSTRACT

OBJECTIVES:

To identify ultrasound (US) features of lymphomas (L) of major salivary glands (SGs) in primary Sjögren's syndrome (pSS) patients and to differentiate US pattern of L and non-L.

METHODS:

Prospectively, from September 2019 to March 2021, 27 pSS-patients with clinical findings suspicious for L of the SGs underwent US evaluation followed by US-guided core-needle biopsy (CNB). For each patient, we assessed the OMERACT score, dichotomised (0/1 "lower", 2/3 "higher"), and we compared it between L-pSS and nonL-pSS groups. For focal lesions, echogenicity, inner appearance, shape, margins, presence of septa, vascularisation and posterior acoustic features were also assessed and compared between the two groups; we planned to consider as "suspicious" features more frequently associated with L. We expected to compare frequencies at which two or more "suspicious" features were simultaneously present between L-pSS and nonL-pSS. P<0.05 were considered statistically significant.

RESULTS:

L-pSS showed more inhomogeneous glandular pattern (100% vs. 69.2% higher OMERACT; p=0.0407). For focal lesions, the "suspicious" features identified were OMERACT grade 3, very hypoechoic, homogenous, oval shape, well-defined margins, presence of septa, colour-Doppler vascularization, posterior acoustic enhancement. 6/8 and 7/8 simultaneous suspicious features were significantly higher among L-pSS patients, compared to nonL-pSS (88.9% vs. 28.6%, p=0.034 for 6/8 features; 77.8% vs. 14.3%, p=0.040 for 7/8 features).

CONCLUSIONS:

L of the major SGs in pSS was always associated with OMERACT scores 2 or 3 and presented with diffuse or focal patterns. For focal lesions, the association of more "suspicious" features made the diagnosis of L increasingly more likely. This information can help to improve planning of US-guided CNB.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren / Linfoma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Sjogren / Linfoma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Exp Rheumatol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália